# COVID-19 Questionnaire

### Purpose
Daily symptom monitoring for patients with confirmed COVID-19 diagnosis, focusing on:
1. Emergency warning signs requiring immediate medical attention (911 criteria)
2. Respiratory deterioration
3. Systemic symptoms and disease progression

### Administration Frequency
- **Acute Care**: Daily during active infection (2-6 days)
- **Post-Acute Care**: Daily for first 14 days post-diagnosis

---

## COVID-19 Daily Symptom Checker

### Section A: EMERGENCY SYMPTOMS (911 Criteria)

**Question 1: Do you have ANY of these life-threatening symptoms?**

**If YES to ANY of the following, call 911 immediately:**

- ☐ Pale, gray, or **blue-colored skin, lips, or nail beds** (depending on skin tone)
- ☐ Severe and constant **pain or pressure in the chest**
- ☐ **Difficulty breathing** such as:
  - Gasping for air
  - Unable to walk or talk without catching your breath
  - Severe wheezing
  - Nostrils flaring, grunting, or ribs/stomach moving in and out deeply and rapidly as you breathe
- ☐ New **disorientation** (acting confused)
- ☐ **Unconscious** or very difficult to wake up
- ☐ **Slurred speech** or difficulty speaking (new or worsening)
- ☐ New or worsening **seizures**
- ☐ Signs of **low blood pressure**:
  - Too weak to stand
  - Dizziness, lightheaded
  - Feeling cold, pale, clammy skin
- ☐ Signs of **dehydration**:
  - Dry lips and mouth
  - Not urinating much
  - Sunken eyes
- ☐ **None of the above**

**IF ANY EMERGENCY SYMPTOM SELECTED (except "None") → STOP QUESTIONNAIRE, CALL 911**

---

### Section B: Respiratory Symptoms

| Question # | Question | Response Options |
|------------|----------|------------------|
| B1 | Are you experiencing any **cough, wheezing, or shortness of breath**? | • Yes<br>• No |
| B2 | Were there any **changes in your breathing** since yesterday? | • No difficulty breathing<br>• Increased shortness of breath with **moderate activity** (walking, climbing stairs)<br>• Increased shortness of breath with **mild activity** (showering, minimal walking)<br>• Increased shortness of breath **at rest** |
| B3 | Have you noticed an **increase in your coughing**? | • Yes<br>• No |
| B4 | Did you experience any issues with your **breathing** yesterday while completing activities? | • No shortness of breath<br>• Some shortness of breath<br>• Short of breath<br>• Increased shortness of breath<br>• Extreme shortness of breath |

---

### Section C: Systemic Symptoms

| Question # | Question | Response Options |
|------------|----------|------------------|
| C1 | In the past 24 hours, have you experienced a **fever**? | • No<br>• Less than 37.2°C<br>• 37.2 to 38.9°C<br>• 39 to 40°C<br>• Greater than 40°C<br>• Did not take temperature – I just feel warm |
| C2 | Have you experienced any of the following as **new onset or worsening symptoms**? *(Select all that apply)* | • Sore throat<br>• Muscle aches or body aches<br>• Unusual fatigue<br>• Headache<br>• New loss of taste or smell<br>• Congestion or runny nose<br>• Nausea or vomiting<br>• Diarrhea<br>• Other symptoms *(free text)*<br>• No symptoms |

---

## Clinical Interpretation

### Section A: Emergency Warning Signs

These criteria are adapted from CDC COVID-19 emergency warning signs. **ANY of these require immediate 911 call and emergency department transfer.**

#### Hypoxemia Indicators

**Cyanosis** (blue lips, skin, nail beds):
- Indicates severe hypoxemia (SpO2 likely <85%)
- **Immediate action**: Call 911, do not transport by car
- May require intubation and mechanical ventilation

**Severe respiratory distress**:
- Gasping, inability to speak in full sentences, accessory muscle use
- **Immediate action**: Call 911, high-flow oxygen, prone positioning while waiting

#### Cardiovascular/Neurological Emergencies

**Chest pain/pressure**:
- May indicate:
  - **Myocardial infarction**: COVID increases MI risk 3-8x
  - **Pulmonary embolism**: COVID is hypercoagulable state
  - **Myocarditis/pericarditis**: Direct viral cardiac involvement

**Altered mental status**:
- Confusion, disorientation, difficulty waking
- Etiologies:
  - **Hypoxic encephalopathy**: Silent hypoxemia (SpO2 <80%)
  - **COVID-associated encephalopathy**: Direct CNS involvement
  - **Stroke**: COVID increases stroke risk
  - **Delirium**: Multifactorial in severe illness

**Seizures**:
- New-onset seizures with COVID suggest:
  - Severe hypoxemia
  - Electrolyte abnormalities
  - CNS involvement (encephalitis)

#### Shock Indicators

**Signs of hypoperfusion**:
- Hypotension (unable to stand, dizzy), cool/clammy skin
- Indicates possible **septic shock** or **cardiogenic shock**
- Requires emergency IV fluids, vasopressors, ICU care

**Dehydration**:
- From decreased oral intake, fever, vomiting/diarrhea
- Can lead to prerenal acute kidney injury
- May require IV hydration

---

### Section B: Respiratory Status Monitoring

#### COVID Pneumonia Progression Patterns

**Day 1-5**: Upper respiratory symptoms (congestion, sore throat, dry cough)
**Day 5-8**: Potential progression to lower respiratory tract (dyspnea, hypoxemia)
**Day 8-12**: Peak severity; risk of ARDS in severe cases
**Day 14+**: Recovery phase (or ongoing chronic symptoms in some)

#### Dyspnea Severity Classification (B2)

| B2 Response | Severity | SpO2 Likely | Action |
|-------------|----------|-------------|--------|
| No difficulty breathing | Mild | >95% | Continue monitoring |
| SOB with **moderate activity** | Moderate | 92-95% | Increase monitoring frequency, oxygen if SpO2 <94% |
| SOB with **mild activity** | Severe | 88-92% | **Urgent evaluation**: Likely needs oxygen, consider hospital admission |
| SOB **at rest** | Critical | <88% | **EMERGENCY**: Call 911, high-flow oxygen |

#### Silent Hypoxemia ("Happy Hypoxics")

**Key Concept**: Some COVID patients have severe hypoxemia (SpO2 <90%) without dyspnea.
- **Always check SpO2**, even if patient denies shortness of breath
- Pulseox readings more reliable than subjective symptoms in COVID

**Red Flag**:
- Patient reports "feeling fine" but SpO2 <92% → High risk for rapid decompensation

#### Cough Assessment (B3)

**Increasing cough interpretation**:
- **Dry cough** (early COVID): Upper airway involvement
- **Productive cough** (later COVID): Lower respiratory tract involvement
- **Worsening cough after improvement**: Possible bacterial superinfection

---

### Section C: Systemic Symptoms

#### Fever (C1)

**COVID Fever Patterns**:
- **Low-grade** (37.2-38.5°C): Common, may persist 5-10 days
- **High-grade** (>38.5°C): More severe disease, higher viral load
- **Prolonged fever** (>7 days): Associated with worse outcomes
- **Biphasic fever** (improves, then recurs): Possible bacterial superinfection

**Management**:
- Antipyretics (acetaminophen, ibuprofen) for comfort
- Fever >40°C: Urgent evaluation for sepsis, bacterial co-infection
- Persistent fever beyond 10 days: Consider imaging for complications

#### Constitutional Symptoms (C2)

**Classic COVID Symptom Constellation**:
- **Sore throat + congestion**: Upper respiratory phase (days 1-5)
- **Muscle aches + fatigue**: Systemic inflammatory response
- **Loss of taste/smell**: Pathognomonic for COVID (vs other URI)
  - Usually develops day 3-5
  - May persist weeks to months (long COVID)
  - Anosmia alone without other symptoms → Less severe disease

**GI Symptoms**:
- **Nausea/vomiting/diarrhea**: Present in ~20% of COVID patients
- May be only symptom (atypical presentation)
- Associated with ACE2 receptors in GI tract

**Headache**:
- Common (70% of patients)
- Severe headache + fever + confusion → Meningoencephalitis (rare)

**Persistent/Worsening Symptoms**:
- Symptom improvement followed by worsening at day 7-10: **Cytokine storm** or **bacterial superinfection**
- Requires urgent clinical evaluation

---

## Risk Stratification

### Disease Severity Classification

| Classification | Clinical Features | Management Setting |
|---------------|-------------------|-------------------|
| **Mild** | No dyspnea, SpO2 >95%, mild symptoms | Outpatient monitoring |
| **Moderate** | Dyspnea on exertion, SpO2 92-95% | Outpatient with close monitoring OR hospitalization |
| **Severe** | Dyspnea at rest, SpO2 <92%, RR >30 | **Hospitalization** |
| **Critical** | Respiratory failure, septic shock, multiorgan dysfunction | **ICU** |

### High-Risk Factors for Severe Disease

- Age >65
- Immunocompromised
- Chronic lung disease (COPD, asthma)
- Diabetes
- Cardiovascular disease
- Obesity (BMI >30)
- Chronic kidney disease
- Pregnancy

**High-risk patients with ANY worsening symptoms → Lower threshold for escalation**

---

## Treatment Considerations

### Monitoring Intensity

| Disease Phase | Monitoring Frequency | Key Parameters |
|--------------|----------------------|----------------|
| **Days 1-5** (Early) | Daily questionnaire, Twice daily temperature, Daily SpO2 | Symptom tracking, fever curve |
| **Days 5-10** (Critical window) | **Twice daily questionnaire**, Twice daily temperature, **Q6hr SpO2** | Watch for progression to pneumonia |
| **Days 10-14** (Recovery or complication) | Daily questionnaire, Daily temperature, Daily SpO2 | Confirm improvement vs complication |

### Antiviral Therapy Window

**Paxlovid (nirmatrelvir/ritonavir)**:
- Effective if started within **5 days** of symptom onset
- Reduces hospitalization by ~89% in high-risk patients
- Eligibility: High-risk patients, mild-moderate disease

**Remdesivir**:
- For hospitalized patients OR high-risk outpatients
- 3-day course for outpatients within 7 days of symptom onset

### Oxygen Therapy

**Indications**:
- SpO2 <94% at rest
- SpO2 drop >4% with exertion
- Dyspnea at rest

**Delivery**:
- Nasal cannula 2-6L/min (target SpO2 >92%)
- If requiring >6L → Consider hospital admission

---

## Correlation with Objective Data

### SpO2 Monitoring

**Critical SpO2 Thresholds**:
- **>95%**: Normal, low-risk
- **92-94%**: Borderline, increase monitoring
- **88-92%**: Hypoxemia, oxygen therapy needed
- **<88%**: Severe hypoxemia, urgent hospital evaluation

**Silent Hypoxemia Detection**:
- Check SpO2 even if patient denies dyspnea
- Check during activity (6-minute walk test at home)
- Prone positioning can improve SpO2 by 2-5%

### Temperature Monitoring

**Twice daily** (morning and evening):
- Track fever curve (should trend downward by day 5-7)
- Document maximum daily temperature
- Persistent fever >7 days → Evaluate for complications

---

## Documentation Template

```
COVID-19 Symptom Check - Day [X] of Illness

Emergency Symptoms: [None / ***SEE SECTION A - 911 CALLED***]

Respiratory Status:
- Dyspnea: [Level from B2]
- Cough: [Present / Absent, Dry / Productive]
- SpO2: [X]% on [room air / oxygen]
- Respiratory rate: [X]/min

Systemic Symptoms:
- Temperature: [X]°C (morning), [Y]°C (evening)
- Fever: [Afebrile / Low-grade / High-grade]
- Other symptoms: [List from C2]

Disease Trajectory:
- [Improving / Stable / Worsening]
- Day of illness: [X]
- Critical window (days 5-10): [Yes / No]

Assessment:
- Severity: [Mild / Moderate / Severe]
- High-risk patient: [Yes / No]
- Antiviral therapy: [Eligible / Not indicated / Already completed]

Plan:
- [Continue home monitoring]
- [Increase monitoring frequency - critical window]
- [Start oxygen therapy]
- [Urgent clinical evaluation]
- [Consider antiviral therapy if within 5 days]
- [Call 911 if emergency symptoms develop]
```

---

## References

- CDC COVID-19 Emergency Warning Signs
- NIH COVID-19 Treatment Guidelines
- WHO Clinical Management of COVID-19: Living Guideline
- Guan WJ, et al. Clinical characteristics of COVID-19 in China. N Engl J Med. 2020.
- Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022.

---

**Clinical Note**: COVID-19 has highly variable presentation and course. The critical window for progression to severe disease is typically days 5-10 after symptom onset. Silent hypoxemia is a unique feature of COVID pneumonia; always check SpO2 even if patient denies dyspnea. Emergency symptoms (Section A) require immediate 911 call - do not delay for further assessment.
